The first few steps to understand the 'forgotten' ventricle during ECMO runs.....

Neurologic complications in post-cardiotomy #ECLS according to cannulation strategy, PC-ECLS study: 🩸subclavian/axillary used in pts with compromised vascular status; associated w ⬆️major neuro-complications/seizure 🪦aortic: ⬆️ in-hospital mortality 🔓rdcu.be/dQop8

ECMO mobilisation water drill at the #APICS2024 pre congress workshops. Lots learnt and shared! Thanks to Ramanathan KR! Amazing teamwork by the NUH cardiothoracic team! #icurehab

Opens up a box of further questions.......nevertheless some light on COVID patients needing ECMO and other immunomodulators including steroids.

- Higher incidence of bleeding complications and secondary infections in the steroid/immunomodulator group - Some insight into a pertinent clinical question on whether such drugs should be continued after ECMO initiation.

Interesting study. Explains some of our findings from the ELSO registry!! Kiran Shekar Graeme MacLaren M Velia Antonini Ryan Ruiyang Ling Ryan Barbaro

Acute hypoxemic respiratory failure in #ICU in 🇦🇺🇳🇿: disease burden may be higher than expected! 🪦mortality ⬆️ with ⬇️ P/F, particularly <200: need to reconsider how we stratify AHRF severity? 🪦mortality ⬇️ over time: improvements in critical care? 🔓 bit.ly/3Xrdh8E

🫁🫀Position statements aimed to improve definition & management of RV injury in adults with respiratory failure receiving VV #ECMO support: the Protecting Right Ventricle network PRORVnet Delphi study published #FOAMcc on September issue of Intensive Care Medicine 🔓 rdcu.be/dTlKR

ECMO as a bridge vs destination therapy.... the path ahead. Pros and Cons The Lancet Respiratory Medicine thelancet.com/journals/lanre… thelancet.com/journals/lanre… ELSO M Velia Antonini Ryan Ruiyang Ling Kiran Shekar

🌊 When #ECMO-dependent patients are no longer candidates for destination therapy, should #ECLS be continued indefinitely? It would eventually serve only as a bridge to fatal complication. Complications might prolong suffering and affect quality of life. Beyond ethical

How should we deal with ECMO when transition to recovery or transplant is no longer possible! Let’s discuss! Kiran Shekar Ramanathan KR Ryan Ruiyang Ling Tobias Wengenmayer Dirk Westermann Dawid Staudacher Justyna Swol MD • ECMOdaily Stefan Kluge ECMO_Karagiannidis Interdisziplinäre Medizinische Intensivtherapie FR thelancet.com/journals/lanre…

Management of cardiogenic shock, state-of-the-art 🩺 definition of CS, pathophysiology, clinical & hemodynamic phenotypes 🌈 heterogeneity of CS clinical syndrome 💊 pharmacologic management ⚙️ mechanical circulatory support devices 🔮 future directions 🔓 bit.ly/3XipcV3

🫀 Management of cardiogenic shock: comprehensive review of latest evidence regarding definition & classification, pathophysiology, workup, (personalized) management, including use of temporary #MCS as #ECMO & #Impella. #FOAMcc on Intensive Care Medicine 🔓 bit.ly/3XipcV3

A random sign at Detroit airport. Looks like Detroit is ready to host #ELSO2024 ELSO M Velia Antonini It’s gonna be great!

Highlights of 2024 ELSO consensus guidelines on neurological monitoring & management for adult #ECMO presented at #ELSO2024 with a dedicated editorial just out #FOAMcc on asaiojournal 🖥️ neuromonitoring and neuroimaging 🛌 bedside management: arterial O2 & CO2,

Neurological monitoring & management in #ECMO: ELSO guidelines 🩺 assessment & monitoring 🌡️bedside management: PaO2/CO2, temperature, BP 🧠interventional neurology, neurosurgery, neurocritical care 🔮prognostication in #ECLS & #ECPR 🪦death determination Open access on

Here’s to the memory of Dr Robert E Gross and to the ongoing love and abiding affection we have for Dr Robert H Bartlett and Wanda Bartlett, without whom #ECMO and >100,000 patients would likely not exist ELSO M Velia Antonini GMA youtu.be/4sfPgPIQ49s?si… via YouTube

- Data analysis from ELSO Registry - Outcome of patients with TB on ECMO - Weaning success rate 62.7% - 55% survival to hospital discharge

Outcome of patients with TB on ECMO - Weaning success rate 62.7% - 55% survival to hospital discharge sciencedirect.com/science/articl….

On the topic, also read this ELSO registry analysis including 169 patients: weaning rate 62.7 %, 55 % survival to hospital discharge. Complications, infections, prolonged time to initiate ECMO correlated with decreased survival. 🔗 bit.ly/47Zfyfb